This work is licensed under the Creative Commons Attribution 4.0 International License.
Dreyer CW. Thesis: Clast cell activity in a model of aseptic root resorption. Orthodontic Adelaide: The University of Adelaide, 2002.Search in Google Scholar
Curl L, Sampson W. The presence of TNF-alpha and TNFR1 in aseptic root resorption; A preliminary study. Aust Orthod J 2011;27:102-9.Search in Google Scholar
Brezniak N, Wasserstein A. Orthodontically induced inflammatory root resorption. Part I: The basic science aspects. Angle Orthod 2002;27:175-9.Search in Google Scholar
Simonet WS, Lacey DL, Dunstan CR Kelley M, Chang MS, Lüthy R et al. Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell 1997;89:309-19.Search in Google Scholar
Phan TC, Xu J, Zheng MH. Interaction between osteoblast and osteoclast: impact in bone disease. Histol Histopathol 2004;19:1325-44.Search in Google Scholar
Takayanagi H. Mechanistic insight into osteoclast differentiation in osteoimmunology. J Mol Med 2005;83:170-9.Search in Google Scholar
Wise GE, Yao S, Zhang Q, Ren Y. Inhibition of osteoclastogenesis by the secretion of osteoprotegerin in vitro by rat dental follicle cells and its implication for tooth eruption. Arch Oral Biol 2002;47:247-54.Search in Google Scholar
Wada N, Maeda H, Yoshimine Y, Akamine A. Lipopolysaccharide stimulates expression of osteoprotegerin and receptor activator of NF-kappa B ligand in periodontal ligament fibroblasts through the induction of interleukin-1 beta and tumor necrosis factor-alpha. Bone 2004;35:629-35.Search in Google Scholar
Yun TJ, Chaudhary PM, Shu GL, Frazer JK, Ewings MK, Schwartz SM et al. OPG/FDCR-1, a TNF receptor family member, is expressed in lymphoid cells and is up-regulated by ligating CD40. J Immunol 1998;161:6113-21.Search in Google Scholar
Tsuda E, Goto M, Mochizuki S, Yano K, Kobayashi F, Morinaga T et al. Isolation of a novel cytokine from human fibroblasts that specifically inhibits osteoclastogenesis. Biochem Biophys Res Commun 1997;234:137-42Search in Google Scholar
Ross AB, Bateman TA, Kostenuik P, Ferguson VL, Lacey DL, Dunstan CR et al. The effects of osteoprotegerin on the mechanical properties of rat bone. J Mater Sci Mater Med 2001;12:583-8.Search in Google Scholar
Min H, Morony S, Sarosi I, Dunstan CR, Capparelli C, Scully S et al. Osteoprotegerin reverses osteoporosis by inhibiting endosteal osteoclasts and prevents vascular calcification by blocking a process resembling osteoclastogenesis. J Exp Med 2000;192:463-74.Search in Google Scholar
Goldberg AF BT. Acid Phosphatase activity in human blood cells. Nature 1962:195-297.Search in Google Scholar
Wesselink PR, Beertsen W, Everts V. Resorption of the mouse incisor after the application of cold to the periodontal attachment apparatus. Calcif Tissue Int 1986;39:11-21.Search in Google Scholar
Tal H, Kozlovsky A, Pitaru S. Healing of sites within the dog periodontal ligament after application of cold to periodontal apparatus. J Clin Periodontol 1991;18:543-6.Search in Google Scholar
Andersson GN, Marks SC. Tartrate-resistant acid ATPase as a cytochemical marker for osteoclasts. J Histochem Cytochem 1989;37:115-17.Search in Google Scholar
Andersson GN, Lindunger A, Ek-Rylander B. Isolation and characterization of skeletal acid ATPase: a new osteoclast marker? Connect Tissue Res 1989;20:151-8.Search in Google Scholar
Hattersley G, Chambers TJ. Generation of osteoclastic function in mouse bone marrow cultures: Multinuclearity and tartrate-resistant acid phosphatase are unreliable markers for ostoclast differentiation. Endocrinology 1989;124:1689-96.Search in Google Scholar
Modderman WE, Tuinenburg-Bol Raap AC, Nijweide PJ. Tartrate-resistant acid phosphate is not an exclusive marker for mouse osteoblasts in cell cultures. Bone 1991;12:81-7.Search in Google Scholar
Suda T, Takahashi N, Martin TJ. Modulation of osteoclast differentiation. Endocr Rev 1992;13:66-80.Search in Google Scholar
Lacey DL, Timms E, Tan H, Kelley MJ, Dunstan CR, Burgess T et al. Osteoprotegerin ligand is a cytoskine that regulates osteoclast differentiation and activation. Cell 1998;93: 165-76.Search in Google Scholar
Khosla S. Minireview: the OPG/RANKL/RANK system. Endocrinology 2001;142:5050-5.Search in Google Scholar
Theoleyre S, Wittrant Y, Tat SK, Fortun Y, Redini F, Heymann D. The molecular triad OPG/RANK/RANKL: involvement in the orchestration of pathophysiological bone remodeling. Cytokine Growth Factor Rev 2004;15:457-75.Search in Google Scholar
Capparelli C, Morony S, Warmington K, Adamu S, Lacey D, Dunstan CR et al. Sustained antiresorptive effects after a single treatment with human recombinant osteoprotegerin (OPG): a pharmacodynamic and pharmokinetic analysis in rats. J Bone Miner Res 2003;18:852-8.Search in Google Scholar
Lane P. Thesis: A histomorphetric investigation into the dffects of osteoprotegerin on tooth movement in rats. Adelaide: Orthodontic Department, School of Dentistry, 2004.Search in Google Scholar
Bekker PJ, Holloway D, Nakanishi A, Arrighi M, Leese PT, Dunstan CR. The effect of a single dose of osteoprotegerin in postmenopausal women. J Bone Miner Res 2001;16:348-60.Search in Google Scholar
Bolon B, Campagnuolo G, Feige U. Duration of bone protection by a single osteoprotegerin injection in rats with adjuvant-induced arthritis. Cell Mol Life Sci 2002;59:1569-76.Search in Google Scholar
Bolon BC, Carter C, Daris M, Morony S, Capparelli C, Hsieh A. Adenoviral delivery of osteoprotegerin ameilorates bone resportion in a mouse ovariectomy model of osteoporosis. Mol Ther 2001;3:197-205.Search in Google Scholar
Atkins GJ, Boualexis S, Haynes D, Graves SE, Geary SM, Evdokiou A et al. Osteoprotegerin inhibits osteoclast formation and bone resorbing activity in giant cell tumors of bone. Bone 2001;28:370-7.Search in Google Scholar
Romas E, Sims NA, Hards DK, Lindsay M, Quinn JW, Ryan PF et al. Osteoprotegerin reduces osteoclast numbers and prevents bone erosin in collagen-induced arthritis. Am J Pathol 2002;161:1419-27.Search in Google Scholar
